GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » PE Ratio

CVS (CVS Health) PE Ratio : 13.24 (As of Dec. 11, 2024)


View and export this data going back to 1952. Start your Free Trial

What is CVS Health PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-11), CVS Health's share price is $52.16. CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $3.94. Therefore, CVS Health's PE Ratio for today is 13.24.

During the past 13 years, CVS Health's highest PE Ratio was 41.87. The lowest was 9.11. And the median was 16.32.

CVS Health's EPS (Diluted) for the three months ended in Sep. 2024 was $0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $3.94.

As of today (2024-12-11), CVS Health's share price is $52.16. CVS Health's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $5.93. Therefore, CVS Health's PE Ratio without NRI ratio for today is 8.80.

During the past 13 years, CVS Health's highest PE Ratio without NRI was 25.50. The lowest was 7.99. And the median was 12.59.

CVS Health's EPS without NRI for the three months ended in Sep. 2024 was $1.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $5.93.

During the past 12 months, CVS Health's average EPS without NRI Growth Rate was -23.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 5.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 4.70% per year.

During the past 13 years, CVS Health's highest 3-Year average EPS without NRI Growth Rate was 35.10% per year. The lowest was -40.50% per year. And the median was 11.70% per year.

CVS Health's EPS (Basic) for the three months ended in Sep. 2024 was $0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $3.95.

Back to Basics: PE Ratio


CVS Health PE Ratio Historical Data

The historical data trend for CVS Health's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health PE Ratio Chart

CVS Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.62 12.51 17.14 28.59 12.20

CVS Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.53 12.20 14.02 10.51 15.96

Competitive Comparison of CVS Health's PE Ratio

For the Healthcare Plans subindustry, CVS Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health's PE Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where CVS Health's PE Ratio falls into.



CVS Health PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

CVS Health's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=52.16/3.940
=13.24

CVS Health's Share Price of today is $52.16.
CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.94.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


CVS Health  (NYSE:CVS) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


CVS Health PE Ratio Related Terms

Thank you for viewing the detailed overview of CVS Health's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CVS Health Business Description

Address
One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Executives
Michael F Mahoney director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Prem S Shah officer: EVP and Co-President of Retail ONE CVS DRIVE, WOONSOCKET RI 02895
Thomas F. Cowhey officer: SVP, Interim CFO 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
J Scott Kirby director 233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606
Brian A Kane officer: EVP/President, Aetna 500 W MAIN STREET, LOUISVILLE KY 40202
James David Clark officer: SVP, Cont & Chief Acct Officer ONE CVS DRIVE, WOONSOCKET RI 02760
Karen S Lynch officer: EVP & Pres, Aetna Bus Unit 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Samrat S. Khichi officer: EVP, CPO and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas M Moriarty officer: EVP & General Counsel 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Alan Lotvin officer: EVP, Transformation 55 NOD ROAD, AVON CT 06001
Daniel P Finke officer: EVP/Pres, Health Care Benefits ONE CVS DRIVE, WOONSOCKET RI 02895
Tilak Mandadi officer: EVP, Chief Technology Officer 3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109
Sreekanth K Chaguturu officer: EVP and Chief Medical Officer ONE CVS DRIVE, WOONSOCKET RI 02895